B. Kunz - Academia.edu (original) (raw)

Uploads

Papers by B. Kunz

Research paper thumbnail of Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts

Journal of the European Academy of Dermatology and Venereology, 2021

Research paper thumbnail of 820 Month of birth (MB) is not a major determinant of allergic sensitization or atopic disease among bavarian children

Journal of Allergy and Clinical Immunology, 1991

Research paper thumbnail of ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

Journal of the European Academy of Dermatology and Venereology, 2016

Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin diseas... more Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using evaluated clinical criteria. Disease activity is best measured with a composite score assessing both objective signs and subjective symptoms, such as SCORAD. The management of AD must consider the clinical and pathogenic variabilities of the disease and also target flare prevention. Basic therapy includes hydrating topical treatment, as well as avoidance of specific and unspecific provocation factors. Anti‐inflammatory treatment of visible skin lesions is based on topical glucocorticosteroids and the topical calcineurin inhibitors tacrolimus and pimecrolimus. Topical calcineurin inhibitors are preferred in sensitive locations. Tacrolimus and mid‐potent steroids are proven for proactive therapy, which is long‐term intermittent anti‐inflammatory therapy of the frequently relapsing skin areas. Systemic anti‐inflammatory or immunosuppress...

Research paper thumbnail of Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

Allergy, 2011

Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Orga... more Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28).

Research paper thumbnail of Indoor air pollution and allergen exposure in homes of atopic eczema patients

Journal of Dermatological Science - J DERMATOLOGICAL SCI, 1993

Research paper thumbnail of Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature

Journal of the European Academy of Dermatology and Venereology, 2006

Research paper thumbnail of Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts

Journal of the European Academy of Dermatology and Venereology, 2021

Research paper thumbnail of 820 Month of birth (MB) is not a major determinant of allergic sensitization or atopic disease among bavarian children

Journal of Allergy and Clinical Immunology, 1991

Research paper thumbnail of ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

Journal of the European Academy of Dermatology and Venereology, 2016

Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin diseas... more Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using evaluated clinical criteria. Disease activity is best measured with a composite score assessing both objective signs and subjective symptoms, such as SCORAD. The management of AD must consider the clinical and pathogenic variabilities of the disease and also target flare prevention. Basic therapy includes hydrating topical treatment, as well as avoidance of specific and unspecific provocation factors. Anti‐inflammatory treatment of visible skin lesions is based on topical glucocorticosteroids and the topical calcineurin inhibitors tacrolimus and pimecrolimus. Topical calcineurin inhibitors are preferred in sensitive locations. Tacrolimus and mid‐potent steroids are proven for proactive therapy, which is long‐term intermittent anti‐inflammatory therapy of the frequently relapsing skin areas. Systemic anti‐inflammatory or immunosuppress...

Research paper thumbnail of Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

Allergy, 2011

Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Orga... more Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28).

Research paper thumbnail of Indoor air pollution and allergen exposure in homes of atopic eczema patients

Journal of Dermatological Science - J DERMATOLOGICAL SCI, 1993

Research paper thumbnail of Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature

Journal of the European Academy of Dermatology and Venereology, 2006

Log In